Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
126.1 USD | -0.42% |
|
+5.05% | -29.89% |
26/06 | Deutsche Bank Upgrades Repligen to Buy From Hold, Cuts Price Target to $155 From $180 | MT |
24/06 | RBC Cuts Price Target on Repligen to $190 From $221, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.89% | 707.33Cr | |
-5.60% | 18TCr | |
-4.45% | 10TCr | |
-4.15% | 6.67TCr | |
-8.63% | 4.56TCr | |
+9.70% | 4.49TCr | |
+6.13% | 4.06TCr | |
+15.22% | 3TCr | |
+14.80% | 2.43TCr | |
-6.46% | 2.39TCr |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Transcript : Repligen Corporation Presents at Wells Fargo Securities Healthcare Conference 2023, Sep-08-2023 10